# CONFIRM: Magnetic Resonance Guided Radiation Therapy

> **NCT04368702** · NA · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Gastric Cancer
- Invasive Breast Cancer
- in Situ Breast Cancer
- Mantle Cell Lymphoma
- Larynx Cancer
- Bladder Cancer

## Interventions

- **RADIATION:** Viewray MRIdian® Linac

## Key facts

- **NCT ID:** NCT04368702
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-01
- **Primary completion:** 2029-06-18
- **Final completion:** 2029-06-18
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04368702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04368702, "CONFIRM: Magnetic Resonance Guided Radiation Therapy". Retrieved via AI Analytics 2026-07-14 from https://api.ai-analytics.org/clinical/NCT04368702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*